Key result
Type III coronary perforation during ACS PCI linked to ~310% higher 3-year mortality vs uncomplicated cases.
Why the study?
Coronary artery perforation is a potentially fatal complication of PCI in ACS, prompting investigation into the in-hospital, 1-year, and 3-year clinical outcomes of type III coronary artery perforation.
Does type III coronary artery perforation during PCI worsen long-term clinical outcomes in patients with acute coronary syndrome?
Case-Control (n=43,344)
Does type III coronary artery perforation during PCI worsen long-term clinical outcomes in patients with acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
Type III coronary artery perforation during PCI for acute coronary syndrome is associated with significantly higher 1-year and 3-year all-cause mortality and adverse cardiovascular events compared to uncomplicated PCI.
Coronary artery perforation (CAP) is a potentially fatal complication of percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS). This study aimed to investigate in-hospital, 1-year, and 3-year clinical outcomes of type III CAP during PCI in patients with ACS. The study retrospectively evaluated 118 patients with CAP and 43,226 case-control patients. Clinical, angiographic, and procedural characteristics, management, and outcomes were analyzed retrospectively at 1-year and 3-year follow-ups. The mean age of the patients was 66.5 ± 11.9 years (61.8% males). There was no significant difference in hospital mortality between the type III CAP and non-CAP groups. The all-cause mortality was 33.3% in the CAP group vs 1.8% in the non-CAP group at 1 year, and 28.3% in CAP group vs 6.9% in non-CAP group at 3 years ( p = .001 for both comparisons). The procedural, clinical, and 1 and 3-year outcomes of type III CAP showed a relatively high risk of myocardial infarction, coronary artery bypass graft, cerebrovascular event, stent thrombosis, and major bleeding at the 1 and 3-year follow-ups. In addition, non-CAP ACS patients had better survival (log-rank: p < .001, 34.29 months 95% Confidence Interval [33.58–35.00]) than type III CAP ACS patients (29.53 months 95% Confidence Interval [27.28–31.78]) at the 3-year follow-up visit.
No takes yet. Share an insight, caveat, or question.
Yıldız et al. (2023) conducted a case-control in Acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) (n=43,344). Type III Coronary Artery Perforation (CAP) vs. Non-CAP was evaluated on All-cause mortality at 3 years (p=.001). Type III coronary artery perforation during PCI in ACS patients was associated with higher all-cause mortality at 3 years compared to non-CAP patients.
Synapse has enriched 10 related papers. Consider them for comparative context: